IL319222A - Engineering SOX/OCT heterodimerization to induce high-level developmental initiation - Google Patents

Engineering SOX/OCT heterodimerization to induce high-level developmental initiation

Info

Publication number
IL319222A
IL319222A IL319222A IL31922225A IL319222A IL 319222 A IL319222 A IL 319222A IL 319222 A IL319222 A IL 319222A IL 31922225 A IL31922225 A IL 31922225A IL 319222 A IL319222 A IL 319222A
Authority
IL
Israel
Prior art keywords
heterodimerization
developmental
oct
grade
reset
Prior art date
Application number
IL319222A
Other languages
English (en)
Hebrew (he)
Original Assignee
Max Planck Gesellschaft Zur F?Rderung Der Wss E V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft Zur F?Rderung Der Wss E V filed Critical Max Planck Gesellschaft Zur F?Rderung Der Wss E V
Publication of IL319222A publication Critical patent/IL319222A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/602—Sox-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C12N2501/603—Oct-3/4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL319222A 2022-09-06 2023-09-06 Engineering SOX/OCT heterodimerization to induce high-level developmental initiation IL319222A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP22194243 2022-09-06
EP23173488 2023-05-15
EP23190084 2023-08-07
PCT/EP2023/074510 WO2024052434A1 (en) 2022-09-06 2023-09-06 Engineering sox/oct heterodimerization to induce high-grade developmental reset

Publications (1)

Publication Number Publication Date
IL319222A true IL319222A (en) 2025-04-01

Family

ID=88017763

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319222A IL319222A (en) 2022-09-06 2023-09-06 Engineering SOX/OCT heterodimerization to induce high-level developmental initiation

Country Status (9)

Country Link
EP (1) EP4584366A1 (de)
JP (1) JP2025530805A (de)
KR (1) KR20250068664A (de)
CN (1) CN121219399A (de)
AU (1) AU2023337518A1 (de)
CA (1) CA3265905A1 (de)
IL (1) IL319222A (de)
MX (1) MX2025002647A (de)
WO (1) WO2024052434A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120607598B (zh) * 2025-05-16 2026-02-27 安徽大学 人源先锋转录因子sox15 hmg结构域重组蛋白及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080560A (en) 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
NZ513487A (en) 1999-01-29 2003-02-28 Univ Illinois The use of a P53 inhibitor for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
EP1892248A1 (de) 2006-08-21 2008-02-27 Eidgenössische Technische Hochschule Zürich Bindeproteine mit spezifischer und hoher Affinität enthaltend modifizierte SH3-Domänen von FYN-Kinasen
SG190628A1 (en) * 2009-11-04 2013-06-28 Agency Science Tech & Res Mutant sox proteins and methods of inducing pluripotency
JP6584776B2 (ja) 2011-04-08 2019-10-02 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 細胞を幼若化するための方法
CN107868126B (zh) * 2017-11-17 2020-04-28 中国科学院广州生物医药与健康研究院 多肽、制备方法及其应用

Also Published As

Publication number Publication date
WO2024052434A1 (en) 2024-03-14
KR20250068664A (ko) 2025-05-16
CA3265905A1 (en) 2024-03-14
JP2025530805A (ja) 2025-09-17
CN121219399A (zh) 2025-12-26
AU2023337518A1 (en) 2025-03-20
EP4584366A1 (de) 2025-07-16
MX2025002647A (es) 2025-06-02

Similar Documents

Publication Publication Date Title
DK3930961T3 (da) Drivsystem konfigureret til tilvejebringelse af friktionsindgreb
DK3340213T3 (da) Puf-baseret kompositsikkerhedsmærkning til bekæmpelse af vareforfalskning
GB2556645B (en) Floating point to fixed point conversion
IL271279B1 (en) Wash buffer for cation exchange chromatography
PL3615166T3 (pl) Oczyszczanie oleju
GB2560766B (en) Floating point to fixed point conversion
IL319222A (en) Engineering SOX/OCT heterodimerization to induce high-level developmental initiation
IL272849A (en) Separation of antibodies with three light chains using cation exchange chromatography
SG11201706503TA (en) System for forming elastomeric compositions for application to metal
HUE054893T2 (hu) Eljárások amorf alacsony kalcium-tartalmú szilikát hidraulikus kötõanyagok elõállítására
MA71371A (fr) Modulateurs de trem2
ZA202104889B (en) Purification of oil
DK3286203T3 (da) Fremgangsmåde til fremstilling af polynukleotid med multivalent kation saltsammensætninger
DK3368492T3 (da) Fremgangsmåde til fremstilling af en cementklinker-substitut, som primært består af kalcineret ler
EP3911772A4 (de) Verfahren zur mineralrückgewinnung
HUE051165T2 (hu) ANG-2 elleni, csak nehézláncot tartalmazó antitestek
EP3962799A4 (de) Verfahren zur durchquerung von schwierigem gelände
GB2550313B (en) Engineering methodology to treat severe loss zones with thixotropic cement system
GB201702388D0 (en) Compositions for application to aerial parts of plants
PL3317376T3 (pl) Sposób konwersji biomasy, w którym wykorzystuje się amorficzną krzemionkę do otrzymywania monoutlenionego strumienia
PL3636600T3 (pl) Kompozycja sorpcyjna do kompleksowego oczyszczania wody
GB201911732D0 (en) Improvements to a drain rod system
GB2560830B (en) Floating point to fixed point conversion
GB202016106D0 (en) Low cost approach to heliostat construction
KR101882054B1 (ko) 금속 할라이드를 제거하기 위한 산업용 공장 부품의 세정